| Wall Street Journal. Europe 2004 Anita Raghavan |
| Title | Subject | Authors |
|---|
| Ahold settles charges in SEC investigation without paying fine.(Ahold NV, Securities and Exchange Commission) | Business, international | Anita Raghavan, Deborah Ball |
| Ahold unit ex-officers are indicted for fraud criminal charges in U.S. are first in case stemming from overstated earnings. | Business, international | Anita Raghavan, Deborah Solomon, Chad Bray |
| Aventis moves to accept sweetened bid by Sanofi.(Sanofi-Synthelabo) | Business, international | Anita Raghavan, John Carreyrou |
| Aventis scrambles to find defense to takeover offer: management rejects the hostile overture, looks at alternatives. | Business, international | Anita Raghavan, Charles Fleming, Sara Calian |
| A Vodafone bid could spark a war over AT&T Wireless: Cingular is prepared to increase its offer; others may join fray. | Business, international | Anita Raghavan, David Pringle, Jason Singer |
| Banco Santander makes bid approach to Abbey National. | Business, international | Carlta Vitzthum, Anita Raghavan |
| Battle intensifies for AT&T Wireless: Vodafone and Cingular submit revised offers as others decline to bid. | Business, international | Anita Raghavan, Almar Latour, Jesse Drucker |
| Novartis, Aventis will talk, dealing blow to Sanofi bid. | Business, international | Gautam Naik, Anita Raghavan, John Carreyrou |
| Novartis CEO goes public with pitch on Aventis deal: in unusual move, Vasella attempts to put pressure on the French government.(Daniel Vasella) | Business, international | Gautam Naik, Anita Raghavan |
| Novartis explores options on Aventis; giant Swiss drug maker weighs white knight role aimed at thwarting Sanofi.(Novartis AG, Aventis SA, Sanofi-Synthelabo SA) | Business, international | Gautam Naik, Anita Raghavan |
| Novartis talks to Aventis about white-knight offer: preliminary discussions come as French drug maker tries to fight off Sanofi bid. | Business, international | Gautam Naik, Anita Raghavan |
| Sanofi is poised to unveil euro 48 billion bid for Aventis: hostile offer would create third-largest drug maker, challenging Pfizer, Glaxo.(Sanofi-Synthelabo S.A.) | Business, international | Gautam Naik, Anita Raghavan, John Carreyrou |
| Spain's Santander, Abbey National of U.K. poised for $15 billion deal . | Business, international | Erik Portanger, Anita Raghavan, Carlta Vitzhum |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
